Duvyzat (Givinostat)

Duvyzat (Givinostat)

Duvyzat

Givinostat

Oral suspension: 8.86 mg/mL givinostat

Italfarmaco

Medical Use

Duvyzat (givinostat) is a histone deacetylase inhibitor prescribed for treating Duchenne muscular dystrophy (DMD) in patients aged 6 years and older.

Dosage Recommendations: The dosage of Duvyzat is determined by body weight and should be taken orally twice a day with food. The recommended dosages for patients aged 6 and above with DMD are as follows:

  • -For patients weighing 10 kg to less than 20 kg: 22.2 mg (2.5 mL) twice daily
  • -For patients weighing 20 kg to less than 40 kg: 31 mg (3.5 mL) twice daily
  • -For patients weighing 40 kg to less than 60 kg: 44.3 mg (5 mL) twice daily
  • -For patients weighing 60 kg or more: 53.2 mg (6 mL) twice daily